Get to know our divisions and growth strategy.
Pharmadrug owns 100% of Sairiyo Therapeutics, a biotech company that specializes in repurposing and reformulating established natural medicines and psychedelics with a goal of bringing them efficiently through the regulatory approval process in multiple jurisdictions. The Company has secured exclusive rights to a novel, enteric-coated and highly bioavailable oral formulation of cepharanthine, a drug that has been in used safely and effectively in Japan for over 70 years to treat multiple forms of cancer and viral disease. The Company also has an active psychedelics R&D program that focuses primarily on novel uses and formulations of DMT (N,N-Dimethyltryptamine).
Pharmadrug owns 100% of Pharmadrug Production GmbH, a German pharmaceutical distributor with a Schedule 1 EU narcotics license and EuGMP supply chain certification allowing for the importation, packaging, and distribution of controlled substances under its own brand to pharmacies in Germany and throughout the European Union. The Company currently distributes third party medical cannabis flowers to over 300 pharmacies in Germany and is launching several medical cannabis products under its own brand in Germany.
Super Smart, a wholly owned subsidiary of Pharmadrug is building a vertically integrated retail business with a goal to elevate the use of psilocybin-containing truffles and functional mushrooms as natural based medicines and supplements. The Company is launching products under its own Slim Winkel brand to be distributed on its own e-commerce platforms in strict accordance with local governing laws.
Pursue novel uses, formulations and delivery forms of psychedelics (DMT) for FDA approval.
Advance clinical development of novel Cepharanthine formulation (Oral Anti-viral) for COVID-19 by leveraging existing safety/efficacy track record.
Repurpose Cepharanthine to treat cancers with high unmet medical needs.
Expand medical cannabis distribution in EU.
Launch branded psychedelic and functional mushrooms products to be sold via our online retail platforms.
Enhance Shareholder value by advancing product pipeline via FDA clinical trials, partnerships, patents, FDA designations, production control, licensing and sales.